Related Experiment Video
Updated: May 25, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
Leukemia inhibitory factor: a paracrine mediator of bone metabolism
Natalie A Sims1, Rachelle W Johnson
1St Vincent's Institute of Medical Research, Melbourne, Victoria 3065, Australia. nsims@svi.edu.au
Insights
Leukemia inhibitory factor (LIF) regulates skeletal remodeling by signaling through LIF receptor (LIFR) and glycoprotein-130. LIF
Area of Science:
- Skeletal Biology
- Cytokine Signaling
- Cell Differentiation
Background:
- Leukemia inhibitory factor (LIF) is an interleukin-6 family cytokine.
- LIF plays a role in physiological functions, including skeletal remodeling.
- LIF signals via LIF receptor (LIFR) and glycoprotein-130 (gp130).
Purpose of the Study:
- To review the expression and regulation of LIF and LIFR in bone.
- To examine LIF's cell-specific effects on skeletal cell differentiation.
- To discuss LIF's role in skeletal growth, maintenance, and disease.
Main Methods:
- Literature review of LIF and LIFR expression and function in the skeletal system.
- Analysis of LIF's influence on osteoblasts, osteoclasts, chondrocytes, and adipocytes.
- Discussion of signaling pathways activated by LIF.
Main Results:
- LIF and LIFR are expressed in various bone cells, including osteoblasts, chondrocytes, and adipocytes.
- LIF exhibits cell-type-specific effects on differentiation, influenced by cell state.
- LIF signaling impacts normal skeletal growth, pathological states, and inflammatory conditions.
Conclusions:
- LIF is a key regulator of skeletal homeostasis and disease.
- Understanding LIF signaling pathways is crucial for bone formation and resorption.
- LIF's diverse roles highlight its therapeutic potential in skeletal disorders.
Abstract:
Leukemia inhibitory factor (LIF) is a soluble interleukin-6 family cytokine that regulates a number of physiologic functions, including normal skeletal remodeling. LIF signals through the cytokine co-receptor glycoprotein-130 in complex with its cytokine-specific receptor [LIF receptor (LIFR)] to activate signaling cascades in cells of the skeletal system, including stromal cells, chondrocytes, osteoblasts, osteocytes, adipocytes, and synovial fibroblasts. LIF action on skeletal cells is cell-type specific, and frequently dependent on the state of cell differentiation. This review describes the expression patterns of LIF and LIFR in bone, their regulation by physiological and inflammatory agents, as well as cell-specific influences of LIF on osteoblast, osteoclast, chondrocyte, and adipocyte differentiation. The actions of LIF in normal skeletal growth and maintenance, in pathological states (e.g. autocrine tumor cell signaling and growth in bone) and inflammatory conditions (e.g. arthritis) will be discussed, as well as the signaling pathways activated by LIF and their importance in bone formation and resorption.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Differentiation of Common Myeloid Progenitor Cells
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...